Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kaynor GC"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jost S; Division of Innate and Comparative Immunology, Center for Human Systems Immunology, Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA., Ahn J; Center for Virology and Vaccine Research, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Chen S; Center for Virology and Vaccine Research, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Yoder T; Center for Virology and Vaccine Research, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Gikundiro KE; Center for Virology and Vaccine Research, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.; Division of Infectious Diseases, Department of Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Lee E; Division of Innate and Comparative Immunology, Center for Human Systems Immunology, Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA., Gressens SB; Division of Innate and Comparative Immunology, Center for Human Systems Immunology, Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA., Kroll K; Division of Innate and Comparative Immunology, Center for Human Systems Immunology, Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA., Craemer M; Division of Innate and Comparative Immunology, Center for Human Systems Immunology, Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA., Kaynor GC; Biogen, Inc, Cambridge, Massachusetts, USA., Lifton M; Center for Virology and Vaccine Research, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Tan CS; Center for Virology and Vaccine Research, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.; Division of Infectious Diseases, Department of Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.; Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Jun 14; Vol. 229 (6), pp. 1836-1844.
Autor:
Oberholster L; Department of Clinical Neurosciences, Laboratory of Neuroimmunology, Neuroscience Research Centre, Lausanne University Hospital (CHUV) and University of Lausanne , Lausanne, Switzerland., Mathias A; Department of Clinical Neurosciences, Laboratory of Neuroimmunology, Neuroscience Research Centre, Lausanne University Hospital (CHUV) and University of Lausanne , Lausanne, Switzerland., Perriot S; Department of Clinical Neurosciences, Laboratory of Neuroimmunology, Neuroscience Research Centre, Lausanne University Hospital (CHUV) and University of Lausanne , Lausanne, Switzerland., Blaser E; Department of Clinical Neurosciences, Laboratory of Neuroimmunology, Neuroscience Research Centre, Lausanne University Hospital (CHUV) and University of Lausanne , Lausanne, Switzerland., Canales M; Department of Clinical Neurosciences, Laboratory of Neuroimmunology, Neuroscience Research Centre, Lausanne University Hospital (CHUV) and University of Lausanne , Lausanne, Switzerland., Jones S; Department of Clinical Neurosciences, Laboratory of Neuroimmunology, Neuroscience Research Centre, Lausanne University Hospital (CHUV) and University of Lausanne , Lausanne, Switzerland., Culebras L; Department of Clinical Neurosciences, Laboratory of Neuroimmunology, Neuroscience Research Centre, Lausanne University Hospital (CHUV) and University of Lausanne , Lausanne, Switzerland.; Department of Psychiatry, Center for Psychiatric Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne , Lausanne, Switzerland., Gimenez M; Department of Clinical Neurosciences, Laboratory of Neuroimmunology, Neuroscience Research Centre, Lausanne University Hospital (CHUV) and University of Lausanne , Lausanne, Switzerland., Kaynor GC; MS&SI, Biogen , Cambridge, Massachusetts, USA., Sapozhnik A; Laboratory for Ultrafast Microscopy and Electron Scattering (LUMES), Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL) , Lausanne, Switzerland., Richetin K; Department of Psychiatry, Center for Psychiatric Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne , Lausanne, Switzerland., Goelz S; MS&SI, Biogen , Cambridge, Massachusetts, USA.; Department of Neurology, Oregon Health and Sciences University , Portland, Oregon, USA., Du Pasquier R; Department of Clinical Neurosciences, Laboratory of Neuroimmunology, Neuroscience Research Centre, Lausanne University Hospital (CHUV) and University of Lausanne , Lausanne, Switzerland.; Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne , Lausanne, Switzerland.
Publikováno v:
Microbiology spectrum [Microbiol Spectr] 2023 Dec 12; Vol. 11 (6), pp. e0275123. Date of Electronic Publication: 2023 Oct 10.
Autor:
Apicco DJ; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142; dan.apicco@gmail.com warren.hirst@biogen.com.; Biogen Postdoctoral Scientist Program, Biogen, Cambridge, MA 02142., Shlevkov E; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142., Nezich CL; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142., Tran DT; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142., Guilmette E; Gene Therapy Accelerator Unit, Biotherapeutics and Medicinal Sciences, Biogen, Cambridge, MA 02142., Nicholatos JW; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142.; Biogen Postdoctoral Scientist Program, Biogen, Cambridge, MA 02142., Bantle CM; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142.; Biogen Postdoctoral Scientist Program, Biogen, Cambridge, MA 02142., Chen Y; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142., Glajch KE; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142., Abraham NA; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142., Dang LT; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142., Kaynor GC; Multiple Sclerosis and Neurorepair Research Unit, Biogen, Cambridge, MA 02142., Tsai EA; Human Genetics, Translational Biology, Biogen, Cambridge, MA 02142., Nguyen KH; Human Genetics, Translational Biology, Biogen, Cambridge, MA 02142., Groot J; Genome Technologies and Scientific Computing, Translational Biology, Biogen, Cambridge, MA 02142., Liu Y; Biologics Drug Discovery, Biotherapeutics and Medicinal Sciences, Biogen, Cambridge, MA 02142., Weihofen A; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142., Hurt JA; Human Target Validation Core, Translational Biology, Biogen, Cambridge, MA 02142., Runz H; Human Genetics, Translational Biology, Biogen, Cambridge, MA 02142., Hirst WD; Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA 02142; dan.apicco@gmail.com warren.hirst@biogen.com.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Jan 05; Vol. 118 (1).
Autor:
Banerjee PT; BioTransplant, Inc., Charlestown, Massachusetts 02129, USA., Ierino F, Kaynor GC, Giovino M, Sablinski T, Emery DW, Rosa MD, LeGuern C, Sachs DH, Monroy RL
Publikováno v:
Transplantation proceedings [Transplant Proc] 1996 Apr; Vol. 28 (2), pp. 747-8.